Diseases, Conditions, Syndromes

Modulating type 1 Interferon may expand treatment options for COVID-19

In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body's initial ...

Medical research

Novel senomorphic agent of natural origin found to target aging

Since the discovery of hallmark features of senescence such as cell cycle arrest, apoptosis resistance and development of a senescence-associated secretory phenotype (SASP), efforts in understanding how senescent cells drive ...

Dentistry

Bacteria in the mouth may be a cause of Crohn's disease

Crohn's disease affects four million people worldwide. The condition causes debilitating symptoms such as chronic fatigue, diarrhea, abdominal pain, weight loss and malnutrition. Once symptoms develop, Crohn's is a lifelong ...

Health informatics

A global overview of antibiotic resistance determinants

To understand the main determinants behind worldwide antibiotic resistance dynamics, scientists from the Institut Pasteur, Inserm, Université de Versailles Saint-Quentin-en-Yvelines and Université Paris-Saclay developed ...

page 10 from 40